Investors Maintain Nerve Repair Co. Axogen Lied In SEC Docs
Investors urged a Florida federal judge Thursday to let them pursue their claim that nerve repair product manufacturer Axogen lied in stock offering materials, saying they have bolstered proof of the...To view the full article, register now.
Already a subscriber? Click here to view full article